Fluidigm (FLDM) Misses Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Fluidigm Recieves ISO 13485 and ISO 9001 Certification at San Francisco and Singapore Facilities
August 4, 2016 4:15 PM EDTSOUTH SAN FRANCISCO, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a pioneer in single-cell analysis, today announced the company has received ISO 13485:2003 and ISO 9001:2008 certification for the design, development, manufacturing and distribution of single-cell genomics and high-throughput genomics systems. The certified San Francisco facility designs and develops instrumentation, IFCs, reagents, and software, and manufactures high-performance genomic reagents and conjugated antibodies. The certified Singapore facility manufactures Fluidigm instruments and integrated fluidic circuits (IFCs) for comprehensive analysis of single cells and nucleic acids from blood, tissues, and tumor samples.
The International... More
